Morana Jovan-Embiricos Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Morana Jovan-Embiricos.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Morana Jovan-Embiricos. Morana Jovan-Embiricos is Director in Radius Health, Inc. ($RDUS) and Director in Allovir, Inc. ($ALVR) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and Director in Cullinan Management, Inc. ($CGEM).
Latest Insider Trading Transactions of Morana Jovan-Embiricos
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALVR, CGEM, RDUS, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | A | 21.51 | 22,500 | 483,975 | 22,500 | |
| May 27 2021 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | A | 21.51 | 22,500 | 483,975 | 22,500 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 1,511,966 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 503,988 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 1,007,977 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 503,988 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 1,282,051 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 3,205,128 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 4,500,000 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 20,500,000 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 8,000,000 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | P | 21.00 | 104,762 | 2,200,002 | 104,762 | 0 to 104.8 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | P | 21.00 | 95,238 | 1,999,998 | 622,175 | 526.9 K to 622.2 K (+18.07 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 214,798 | 0 | 214,798 | 0 to 214.8 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 71,599 | 0 | 71,599 | 0 to 71.6 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 143,198 | 0 | 325,333 | 182.1 K to 325.3 K (+78.62 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 71,599 | 0 | 526,937 | 455.3 K to 526.9 K (+15.72 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 182,135 | 0 | 182,135 | 0 to 182.1 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 455,338 | 0 | 455,338 | 0 to 455.3 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 639,295 | 0 | 639,295 | 0 to 639.3 K |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 2,912,345 | 0 | 2,912,345 | 0 to 2.9 M |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 1,136,525 | 0 | 1,136,525 | 0 to 1.1 M |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 613,496 | 0 | 0 | |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 2,085,889 | 0 | 0 | |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 368,098 | 0 | 0 | |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | P | 17.00 | 2,800,000 | 47,600,000 | 2,800,000 | 0 to 2.8 M |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | P | 17.00 | 100,000 | 1,700,000 | 347,011 | 247 K to 347 K (+40.48 %) |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 411,685 | 0 | 411,685 | 0 to 411.7 K |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 1,399,732 | 0 | 1,399,732 | 0 to 1.4 M |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 247,011 | 0 | 247,011 | 0 to 247 K |
| Aug 06 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 13,420,970 | 0 | 13,420,970 | 0 to 13.4 M |
| Jul 31 2020 | ALVR | Allovir, Inc. | Jovan-Embiricos Morana | Director | Option Exercise | A | 17.00 | 22,500 | 382,500 | 22,500 | |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | J | 0.00 | 13,847 | 0 | 161,024 | 174.9 K to 161 K (-7.92 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | J | 0.00 | 586,153 | 0 | 713,723 | 1.3 M to 713.7 K (-45.09 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 16.47 | 35,323 | 581,819 | 155,986 | 191.3 K to 156 K (-18.46 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 16.47 | 6,642 | 109,403 | 82,575 | 89.2 K to 82.6 K (-7.44 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 2,433 | 41,376 | 191,309 | 193.7 K to 191.3 K (-1.26 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 458 | 7,789 | 89,217 | 89.7 K to 89.2 K (-0.51 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 4,153 | 73,311 | 1,299,876 | 1.3 M to 1.3 M (-0.32 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,054 | 18,606 | 330,238 | 331.3 K to 330.2 K (-0.32 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,381 | 24,378 | 432,319 | 433.7 K to 432.3 K (-0.32 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,155 | 20,389 | 361,665 | 362.8 K to 361.7 K (-0.32 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 30,475 | 537,067 | 1,304,029 | 1.3 M to 1.3 M (-2.28 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 7,741 | 136,421 | 331,292 | 339 K to 331.3 K (-2.28 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 10,135 | 178,611 | 433,700 | 443.8 K to 433.7 K (-2.28 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 8,479 | 149,427 | 362,820 | 371.3 K to 362.8 K (-2.28 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 75,067 | 1,325,015 | 1,334,504 | 1.4 M to 1.3 M (-5.33 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 19,070 | 336,606 | 339,033 | 358.1 K to 339 K (-5.33 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 24,966 | 440,677 | 443,835 | 468.8 K to 443.8 K (-5.33 %) |
| Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 20,886 | 368,661 | 371,299 | 392.2 K to 371.3 K (-5.33 %) |
| Oct 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 15.16 | 2,085 | 31,603 | 1,409,571 | 1.4 M to 1.4 M (-0.15 %) |
| Oct 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 15.16 | 530 | 8,033 | 358,103 | 358.6 K to 358.1 K (-0.15 %) |
| Oct 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 15.16 | 693 | 10,504 | 392,185 | 392.9 K to 392.2 K (-0.18 %) |
| Oct 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 15.16 | 580 | 8,791 | 392,185 | 392.8 K to 392.2 K (-0.15 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 5,516 | 95,490 | 1,411,656 | 1.4 M to 1.4 M (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,401 | 24,253 | 358,633 | 360 K to 358.6 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,835 | 31,766 | 469,464 | 471.3 K to 469.5 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 5,516 | 95,490 | 1,411,656 | 1.4 M to 1.4 M (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 351 | 6,076 | 89,675 | 90 K to 89.7 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,401 | 24,253 | 358,633 | 360 K to 358.6 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 683 | 11,824 | 174,871 | 175.6 K to 174.9 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,835 | 31,766 | 469,464 | 471.3 K to 469.5 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,535 | 26,573 | 392,765 | 394.3 K to 392.8 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 351 | 6,076 | 89,675 | 90 K to 89.7 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 197,343 | 3,539,426 | 1,417,172 | 1.6 M to 1.4 M (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 683 | 11,824 | 174,871 | 175.6 K to 174.9 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 50,134 | 899,173 | 360,034 | 410.2 K to 360 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.31 | 1,535 | 26,573 | 392,765 | 394.3 K to 392.8 K (-0.39 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 65,633 | 1,177,154 | 471,299 | 536.9 K to 471.3 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 197,343 | 3,539,426 | 1,417,172 | 1.6 M to 1.4 M (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 12,537 | 224,856 | 90,026 | 102.6 K to 90 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 50,134 | 899,173 | 360,034 | 410.2 K to 360 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 24,446 | 438,449 | 175,554 | 200 K to 175.6 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 65,633 | 1,177,154 | 471,299 | 536.9 K to 471.3 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 54,907 | 984,779 | 394,300 | 449.2 K to 394.3 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 12,537 | 224,856 | 90,026 | 102.6 K to 90 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 24,446 | 438,449 | 175,554 | 200 K to 175.6 K (-12.22 %) |
| Sep 24 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.94 | 54,907 | 984,779 | 394,300 | 449.2 K to 394.3 K (-12.22 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.55 | 12,214 | 214,414 | 102,563 | 114.8 K to 102.6 K (-10.64 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 10,559 | 179,653 | 114,777 | 125.3 K to 114.8 K (-8.42 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 3,700 | 62,925 | 125,336 | 129 K to 125.3 K (-2.87 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 6,700 | 113,941 | 129,036 | 135.7 K to 129 K (-4.94 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 1,200 | 20,414 | 135,736 | 136.9 K to 135.7 K (-0.88 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 29,128 | 495,479 | 136,936 | 166.1 K to 136.9 K (-17.54 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.00 | 3 | 51 | 166,064 | 166.1 K to 166.1 K (0.00 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.03 | 100 | 1,703 | 166,067 | 166.2 K to 166.1 K (-0.06 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.00 | 500 | 8,500 | 166,167 | 166.7 K to 166.2 K (-0.30 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.55 | 12,214 | 214,414 | 102,563 | 114.8 K to 102.6 K (-10.64 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 10,559 | 179,653 | 114,777 | 125.3 K to 114.8 K (-8.42 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 3,700 | 62,925 | 125,336 | 129 K to 125.3 K (-2.87 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 6,700 | 113,941 | 129,036 | 135.7 K to 129 K (-4.94 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 1,200 | 20,414 | 135,736 | 136.9 K to 135.7 K (-0.88 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 29,128 | 495,479 | 136,936 | 166.1 K to 136.9 K (-17.54 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.00 | 3 | 51 | 166,064 | 166.1 K to 166.1 K (0.00 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.03 | 100 | 1,703 | 166,067 | 166.2 K to 166.1 K (-0.06 %) |
| Sep 05 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.00 | 500 | 8,500 | 166,167 | 166.7 K to 166.2 K (-0.30 %) |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 2,500,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 1,750,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 2,540,500 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 1,200,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 10,000,001 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | P | 15.00 | 133,333 | 1,999,995 | 536,962 | 403.6 K to 537 K (+33.03 %) |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | P | 15.00 | 166,667 | 2,500,005 | 449,207 | 282.5 K to 449.2 K (+58.99 %) |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | P | 15.00 | 166,667 | 2,500,005 | 166,667 | 0 to 166.7 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | P | 15.00 | 200,000 | 3,000,000 | 200,000 | 0 to 200 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 403,629 | 0 | 403,629 | 0 to 403.6 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 282,540 | 0 | 282,540 | 0 to 282.5 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 410,168 | 0 | 410,168 | 0 to 410.2 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 193,742 | 0 | 193,742 | 0 to 193.7 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 1,614,515 | 0 | 1,614,515 | 0 to 1.6 M |
| Jan 15 2015 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Sell | J | 0.00 | 335,820 | 0 | 0 | 335.8 K to 0 (-100.00 %) |
| Jan 15 2015 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Sell | J | 0.00 | 251,680 | 0 | 335,820 | 587.5 K to 335.8 K (-42.84 %) |
| Jan 12 2015 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Option Exercise | J | 2.69 | 89,261 | 240,469 | 267,786 | |
| Jan 12 2015 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Sell | J | 0.00 | 389,331 | 0 | 1,167,997 | 1.6 M to 1.2 M (-25.00 %) |
| Jun 13 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 110,713 | 0 | 0 | |
| Jun 13 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 227,938 | 0 | 0 | |
| Jun 13 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Buy | P | 8.00 | 587,500 | 4,700,000 | 587,500 | 0 to 587.5 K |
| Jun 13 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 871,851 | 0 | 871,851 | 0 to 871.9 K |
| Jun 13 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 1,794,983 | 0 | 1,794,983 | 0 to 1.8 M |
| Jun 10 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Option Exercise | C | 0.00 | 325,627 | 0 | 0 | |
| Jun 10 2014 | RDUS | Radius Health, Inc ... | Jovan-Embiricos Morana | Director | Buy | C | 0.00 | 1,557,328 | 0 | 1,557,328 | 0 to 1.6 M |
Page: 1